At the news
? BULLISHIMPACT 7/10 8-K filed Sep 1, 2026 at 06:50 ET
MiniMed reported Q1 FY27 net sales of $843M (+16.6% YoY as reported, +15.8% organic), with U.S. growth accelerating to 13.1% and international up 18.1%. The company raised FY27 organic revenue growth guidance to ~10.5% from ~10%, while reaffirming ~16% adjusted EBITDA margin. GAAP EPS was $0.00, essentially breakeven vs a loss of -$0.08 a year ago, but this is a medical device company where the Street focuses on revenue growth and pipeline catalysts, not GAAP EPS.
- Worldwide net sales of $843M grew 16.6% as reported and 15.8% organic
- U.S. net sales grew 13.1% YoY, accelerating from 1.5% in Q4 FY26, driven by MiniMed Flex launch
- U.S. New Pumps Sold grew over 20% YoY
- FY27 organic revenue growth guidance raised to ~10.5% from ~10%
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access